GlassScriptPhysician profile
Emily J Moore
NPI 1649413527
$8,406.00
in general payments reported to CMS, 2019-2025
39 companies · $2,710 in 2025
The $2,710 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $759 · 2022: $845 · 2023: $1,012 · 2024: $3,080 · 2025: $2,710.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,802.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,802.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,355.87 | 2021-2025 | Erleada, Akeega, Carvykti |
| Bayer Healthcare Pharmaceuticals INC. | $1,214.92 | 2021-2025 | |
| Teleflex LLC | $1,013.14 | 2021-2025 | Urolift, Barrigel |
| Boston Scientific Corporation | $557.57 | 2021-2025 | Rezum Generator, Axonics, Spaceoar System |
| Astellas Pharma US INC | $509.81 | 2021-2024 | Xtandi, Myrbetriq |
| Antares Pharma, INC. | $411.46 | 2022-2025 | Xyosted, Tlando |
| Pfizer INC. | $380.58 | 2023-2025 | |
| Medtronic, INC. | $311.74 | 2021-2023 | Interstim |
| Janssen Scientific Affairs, LLC | $308.54 | 2024-2025 | Erleada |
| Merck Sharp & Dohme LLC | $232.55 | 2021-2025 | Lynparza, Keytruda, Keytruda Qlex |
| Urogen Pharma, INC. | $224.30 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $202.32 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $201.52 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $161.98 | 2024-2025 | |
| Tolmar, INC. | $142.15 | 2024-2025 | Eligard, Jatenzo |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.